We are live on
!
Find out more
Anika Therapeutics
ANIK
ANIK
131 hedge funds and large institutions have $560M invested in Anika Therapeutics in 2021 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 39 increasing their positions, 51 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
89% more call options, than puts
Call options by funds: $498K | Put options by funds: $264K
0.12% less ownership
Funds ownership: 91.33% → 91.21% (-0.12%)
2% less capital invested
Capital invested by funds: $568M → $560M (-$8.97M)
6% less funds holding
Funds holding: 139 → 131 (-8)
24% less repeat investments, than reductions
Existing positions increased: 39 | Existing positions reduced: 51
54% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 13
Holders
131
Holders Change
-8
Holders Change %
-5.76%
% of All Funds
2.29%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
39
Reduced
51
Closed
13
Calls
$498K
Puts
$264K
Net Calls
+$234K
Net Calls Change
-$81K
Top Buyers
Top Sellers
| 1 |
Baird Financial Group
Milwaukee,
Wisconsin
|
-$5.85M |
| 2 |
State Street
Boston,
Massachusetts
|
-$3.58M |
| 3 |
PGM
Parian Global Management
Pound Ridge,
New York
|
-$2.92M |
| 4 |
PCM
Portolan Capital Management
Boston,
Massachusetts
|
-$2.17M |
| 5 |
Two Sigma Investments
New York
|
-$2.07M |
